CARR Biosystems’ Post

Automated manufacturing systems reduce manual intervention, improve consistency, and lower costs in cell therapy. However, a full transition requires integrating real-time process parameters like glucose and lactate concentrations. Learn how monitoring these key indicators, in synergy with systems like Quantum Flex and MAVEN, can enhance process understanding, optimize media usage, and determine the ideal harvest time to ensure you stay in control. https://bit.ly/4fYo3KP #celltherapy

Check this out and learn more about the latest innovations in cell therapy!

Two common process steps, cell harvest and cell washing, can significantly reduce cell viability if cells are exposed to high shear forces. During these steps, the efficiency of cell recovery is also of critical concern, as cells which escape to waste-streams will not be recovered. We present data demonstrating the performance of a single-use centrifuge (CARR Biosystem’s UniFuge® family) for the harvest of cells in cell therapy production. View a sampling of performance results here: https://hubs.ly/Q02pBlvV0 #CARRBiosystems #Centrifugation #SingleUseCentrifuge #Celltherapy #lifesciences #bioprocessing

Single-use systems can release chemicals known as extractables and leachables (E&L), and identifying E&Ls early is critical to protecting patients and meeting regulatory expectations. Learn how they can impact your therapy development in our upcoming cell therapy expert talk. https://sar.to/cl4z3 #SimplifyingProgress #InThisTogether #AdvancedTherapies #CellandGeneTherapy

Valuable update on impact of E&L on cell therapies and development strategies to deal with this

What’s the biggest hurdle you’ve faced in scaling cell therapy production? Comment below. Check out our latest blog to learn more: https://ow.ly/b1HQ50TPPy3 #CellTherapy #Biomanufacturing #ScalingUp #Biotech

🔍 Have you ever wondered how raw materials are evaluated for cell therapy manufacturing? Our handbook provides a comprehensive framework that categorizes raw materials based on their risk levels. 📚 #CellTherapy

Frustrated with fill and finish steps slowing your cell therapy manufacturing process? You may be interested in this new research conducted by Charles River Laboratories. It showed that the Finia Fill and Finish System can successfully perform four back-to-back runs to process a harvest of T cells. Dose accuracy and cell concentration were maintained across the sequential runs, as was cell health, including viability, functionality, and phenotype. In the study, 12 product bags were completed in about 2 hours with a 60% reduction in hands-on labor. Explore the full study results here: https://bit.ly/4cH7qAt #Finia #celltherapy #biomanufacturing #finalformulation #CAR-T #CGT

On-Demand Webinar: Reduce Waste, Boost Performance, and Future-Proof your Bioprocess Supply Chain! Discover how Nexcel® BIO1250, a film technology by Sealed Air, can revolutionize your bioprocessing operations. Our on-demand webinar explores how to: Extend container lifespans and reduce waste Improve workflow efficiency and cost-effectiveness Ensure compliance with critical industry regulations Watch now and unlock the potential of Nexcel® BIO1250 for your cell culture or cell therapy process: https://lnkd.in/efUjFvGr #bioprocessing #efficiency #wastereduction #cellculture #celltherapy #nexcel #webinar #ondemandwebinar

🚀 Exploring holistic infrastructure development in centralized and decentralized manufacturing. 🌐 Take a few minutes to watch cGMPnow's Grayson Heller and Germfree's Sean Bartholomew discuss transformative strategies at their ATW2024 panel discussion. #Manufacturing #Infrastructure #cGMPnow